Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Horizon Therapeutics and Massachusetts Institute of Technology (MIT) Solve Announce Second Annual Horizon Prize to Inspire Solutions that Improve the Quality of Life for the Global Rare Disease Community

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the kickoff of the second annual global innovation challenge, The Horizon Prize powered by MIT Solve.

The Horizon Prize poses a unique question to encourage entrepreneurs and innovators worldwide to think creatively to solve a problem faced by the more than 400 million people globally living with a rare disease. Up to two winners from a network of thousands of innovators, academics and inventors who submit solutions will be awarded a total of $150,000 in funding.

This year’s question, “How can we improve the quality of life of people who have been diagnosed with a rare disease?,” seeks to find solutions that empower patients with information and resources; promote community and connection; optimize holistic care that supports daily care management; improve data sharing between provider and patient; and mitigate barriers to accessing medical care after diagnosis. Participants can enter here.

“The Horizon Prize gives innovators from around the world an opportunity to develop potential solutions to improve the quality of life for people living with rare diseases,” said Tim Walbert, chairman, president and chief executive officer, Horizon. “I live with a rare disease and know that the journey toward diagnosis can be long and complex, with significant impact on the patient and family’s quality of life. Through the creativity of The Horizon Prize platform, groundbreaking ideas are given the necessary support to thrive and potentially provide life-changing intervention to the rare disease community.”

The inaugural Horizon Prize in 2021 focused on how technology can help improve access to care for those with rare diseases, and the winners – Congenica and ThinkGenetic – brought solutions that supported patients in diagnosis and accessing care.

“The first step in any health journey is diagnosis. Technology gives us the opportunity to help recognize rare diseases in patients at an earlier stage, including groups from medically underrepresented groups,” said Sandro Morganella, Ph.D., head of artificial intelligence, Congenica. “The funding we received from the Horizon Prize in 2021 allows us to expand our use of the data to diagnose rare conditions to help deliver greater health equity across the globe.”

About Horizon

Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.